| Literature DB >> 30854479 |
Arvind K Subbaraj1, Jan Huege2, Karl Fraser2, Mingshu Cao2, Susanne Rasmussen2,3, Marty Faville2, Scott J Harrison2,4, Chris S Jones2,5.
Abstract
Perennial ryegrass (Lolium perenne) is integral to temperate pastoral agriculture, which contributes most of the milk and meat production worldwide. Chemical profiles and diversity of ryegrass offer several opportunities to harness specific traits and elucidate underlying biological mechanisms for forage improvement. We conducted a large-scale metabolomics study of perennial ryegrass comprising 715 genotypes, representing 118 populations from 21 countries. Liquid/gas chromatography-mass spectrometry based targeted and non-targeted techniques were used to analyse fructan oligosaccharides, lipids, fatty acid methyl esters, polar and semi-polar compounds. Fructan diversity across all genotypes was evaluated, high- and low-sugar groups identified, and fructan accumulation mechanisms explored. Metabolites differentiating the two groups were characterised, modules and pathways they represent deduced, and finally, visualisation and interpretation provided in a biological context. We also demonstrate a workflow for large-scale metabolomics studies from raw data through to statistical and pathway analysis. Raw files and metadata are available at the MetaboLights database.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30854479 PMCID: PMC6399292 DOI: 10.1038/s42003-019-0289-6
Source DB: PubMed Journal: Commun Biol ISSN: 2399-3642
Fig. 1Diversity of ryegrass genotypes (open circle, black up pointing triangle, black down pointing triangle) (a) based on total sugar content ±SE (n = 5), with black up pointing triangle denoting the top 10% (high-sugar group) and, black down pointing triangle denoting the bottom 10% (low-sugar group) that fulfilled the two-tier criterion, and b showing the genotypic diversity based on total sugar content, relative to a normal distribution curve
Fig. 2a Boxplots of total sugar content between high- and low-sugar groups, distributed across average peak intensities of low (DP3–5), mid (DP10–12) and high (DP18–20) degree of polymerisation (DP) of fructans. Patterned and shaded boxes denote high- and low-sugar groups, respectively. Different upper case letter codes presented between the two groups, indicate significantly different (p < 0.05) values by Tukey’s HSD. b Correlation analysis (Pearson method) between low-, mid- and high-DP fructans within the 39 high-sugar genotypes. Positive correlations are displayed in blue and negative correlations in red colour. Colour intensity and the size of the circle are proportional to the correlation coefficients. Legend colour at the bottom shows the correlation coefficients and the corresponding colours. c Comparison of average peak intensities ± SE of high- (Patterned bars) and low-DP (shaded bars) fructans across the 39 high-sugar genotypes, along with respective linear regression trends. The high-sugar genotype Aberdart is marked as the current standard. Data underlying the plots in c are available in Supplementary Data 3
Fig. 3Cloudplot of t stat and −log10 p values of metabolic features from the HILIC and C18 streams (positive- and negative-ionisation modes), significantly different between high- and low-sugar groups, based on t tests with a false-discovery rate cut-off of p < 0.05. A positive t stat value indicates high- > low-sugar group, whereas a negative value indicates high- < low-sugar group. Cloud size represents the magnitude of –log10 p value. HP (Purple), HN (Green), CP (Brown) and CN (Blue) represent different analytical streams corresponding to HILIC positive, negative and C18 positive and negative, respectively
Fig. 4Boxplots of peak intensities of lipid classes identified by a the non-targeted lipidomics method and b normalised peak intensities of fatty acid methyl esters (FAMEs) identified by the targeted method, between the high- and low-sugar groups. Different upper case letter codes, where presented between the two groups, indicate significantly different (p < 0.05) values by Tukey’s HSD. LPE lysophosphatidylethanolamine, LPG lysophosphatidylglycerol, LPC lysophosphatidylcholine, PA phosphatidic acid, Pme phosphatidylmethanol, PE phosphatidylethanolamine, PI phosphatidylinositol, PS phosphatidylserine, PG phosphatidylglycerol, PC phosphatidylcholine, TG triglyceride, MGMG monogalactosylmonoacylglycerol, DGMG digalactosylmonoacylglycerol, MGDG monogalactosyldiacylglycerol, SQDG sulfoquinovosyldiacylglycerol, DGDG digalactosyldiacylglycerol, MG monoglyceride, DG diglyceride. C16:0, C16:1, C18:0, C18:1, C18:2 and C18:3 refer to fatty acids with their respective number of carbon atoms and double bonds
Summary of compounds identified by matching with a local library of authentic standards, public domain mass spectral databases and/or Mummichog, with their respective KEGG IDs, analytical stream, univariate statistics and level of confidence in identification
| KEGG ID | Name | Stream | Univariate statistics | Identification | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fold | AUC | Confidence | Library | Database |
| ||||||
| Parent [M ± H]± | Diagnostic |
| Tentative match | ||||||||
| C00317 | Amylopectin | ↑ | HP | 4.62 | 17.11 | 1.0 | Level 3 | 867.2384 | M + K[1+] | ||
| C00208 | Maltose | ↑ | HP | 2.49 | 10.15 | 0.9 | Level 3 | 307.1023, 325.1129, 381.0794 | M–H4O2 + H[1+], M–H2O + H[1+], M + K[1+] | ||
| C01083 | alpha,alpha-Trehalose | ↑ | HP | 2.49 | 10.15 | 0.9 | Level 3 | 307.1023, 325.1129, 381.0794 | M–H4O2 + H[1+], M–H2O + H[1+], M + K[1+] | ||
| C01235 | Galactinol | ↑ | HP | 2.49 | 10.15 | 0.9 | Level 3 | 307.1023, 325.1129, 381.0794 | M–H4O2 + H[1+], M–H2O + H[1+], M + K[1+] | ||
| C04332 | 6,7-Dimethyl-8-(1'-D-Ribityl)Lumazine | ↑ | HP | 2.49 | 10.15 | 0.9 | Level 3 | 325.1129 | M[1+] | ||
| C00117 | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–HCOOK + H[1+] | |||
| C00124 | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–H4O2 + H[1+] | |||
| C00137 | Myo-inositol | ↑ | HN | 2.04 | 9.60 | 0.8 | Level 1 | 179.0556 | |||
| C00221 | Beta- | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–H4O2 + H[1+] | ||
| C00231 | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–HCOOK + H[1+] | |||
| C00267 | Alpha- | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–H4O2 + H[1+] | ||
| C00962 | Beta- | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–H4O2 + H[1+] | ||
| C00966 | 2-Dehydropantoate | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M[1+] | ||
| C01077 | O-acetyl- | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 2 | 102.0550, 74.0609 | 90.0556, 116.071, 118.0867, 145.0496, 180.0867 | M–C3H4O2 + H[1+], M–HCOOH + H[1+], M–CO2 + H[1+], M-NH3 + H[1+], M + H2O + H[1+] | |
| C01112 | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–HCOOK + H[1+] | |||
| C01825 | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–H4O2 + H[1+] | |||
| C01906 | Hamamelose | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 2 | 181.0714, 163.0608 | 145.0496 | M–H4O2 + H[1+] | |
| C02336 | Beta- | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–H4O2 + H[1+] | ||
| C03906 | Beta- | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M–HCOOK + H[1+] | ||
| C04236 | (2S)-2-Isopropyl-3-Oxosuccinate | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 101.0237, 127.0394, 145.0496 | M–C3H4O2 + H[1+], M–HCOOH + H[1+], M–CO + H[1+] | ||
| C06006 | (S)-2-Aceto-2-Hydroxybutanoate | ↑ | HP | 2.04 | 9.60 | 0.8 | Level 3 | 145.0496 | M[1+] | ||
| C00555 | 4-Aminobutyraldehyde | ↑ | HP | 1.70 | 6.95 | 0.8 | Level 3 | 127.0394 | M + K[1+] | ||
| C01210 | N-Methylethanolamine Phosphate | ↑ | HP | 1.70 | 6.95 | 0.8 | Level 3 | 109.0288, 127.0394 | M–HCOOH + H[1+], M–CO + H[1+] | ||
| C02351 | 1,2-Benzoquinone | ↑ | HP | 1.70 | 6.95 | 0.8 | Level 2 | 109.0282, 81.0342 | 109.0288, 81.034, 127.0394 | M + H[1+], M-CO + H[1+], M + H2O + H[1+] | |
| C00296 | Quinate/Quinic acid | ↑ | HN | 2.26 | 6.72 | 0.8 | Level 2 | 191.0554 | |||
| C00111 | Glycerone Phosphate | ↑ | HP | 1.66 | 6.65 | 0.8 | Level 3 | 125.0003, 85.029 | M–CO2 + H[1+], M–HCOOK + H[1+] | ||
| C00661 | ↑ | HP | 1.66 | 6.65 | 0.8 | Level 3 | 125.0003, 85.029 | M–CO2 + H[1+], M–HCOOK + H[1+] | |||
| C01234 | 1-Aminocyclopropane-1-Carboxylate | ↑ | HP | 1.66 | 6.65 | 0.8 | Level 3 | 102.0554, 74.0606, 84.0449, 85.029, 120.066 | M + H[1+], M–CO + H[1+], M–H2O + H[1+], M–NH3 + H[1+], M + H2O + H[1+] | ||
| C02631 | 2-Isopropylmaleate | ↑ | HP | 1.66 | 6.65 | 0.8 | Level 3 | 85.029 | M–C3H4O2 + H[1+] | ||
| C13482 | Phosphodimethylethanolamine | ↑ | HP | 1.66 | 6.65 | 0.8 | Level 3 | 97.029, 85.029 | M–C3H4O2 + H[1+], M + 2 H[2+] | ||
| C17759 | 1-O-Feruloyl-Beta- | ↑ | HN | 1.53 | 4.45 | 0.7 | Level 3 | 337.0929, 371.0984 | M–H2O-H[−], M–H + O[−] | ||
| C10883 | (+)-Sesamolin | ↑ | HN | 1.72 | 3.43 | 0.7 | Level 3 | 371.0984, 390.0726 | M(37Cl)–H[−], M + Na-2H[−] | ||
| C00152 | ↓ | HP | 1.77 | −2.54 | 0.6 | Level 1 | 133.0614 | ||||
| C09315 | Umbelliferone | ↓ | CN | 2.15 | −2.75 | 0.6 | Level 2 | 161.0237, 162.0272 | 161.0239, 202.0505 | M–H[−], M + ACN-H[−] | |
| C01460 | Vitexin | ↓ | CN | 1.65 | −2.75 | 0.6 | Level 2 | 431.0976, 311.0555 | 447.0929, 477.1036 | M–H + O[−], M + HCOO[−] | |
| C01714 | Isovitexin | ↓ | CN | 1.65 | −2.75 | 0.6 | Level 3 | 447.0929, 477.1036 | M-H + O[−], M + HCOO[−] | ||
| C01821 | Isoorientin | ↓ | CN | 1.65 | −2.75 | 0.6 | Level 3 | 447.0929, 506.1017 | M(13C)–H[−], M + CH3COO[−] | ||
| C08604 | Chrysanthemin | ↓ | CN | 1.65 | −2.75 | 0.7 | Level 3 | 447.0929, 463.088, 493.1007, 506.1017 | M–H[−], M–H + O[−], M + HCOO[−], M + CH3COO[−] | ||
| C10114 | Orientin | ↓ | CN | 1.65 | −2.75 | 0.6 | Level 2 | 447.0925, 327.0499 | 447.0929, 506.1017 | M(13C)–H[−], M + CH3COO[−] | |
| C12137 | Pelargonidin-3-O-Beta-D-Glucoside | ↓ | CN | 1.65 | −2.75 | 0.6 | Level 3 | 447.0929, 477.1036 | M–H + O[−], M + HCOO[−] | ||
| C16298 | Cyanidin 5-O-Beta-D-Glucoside | ↓ | CN | 1.65 | −2.75 | 0.6 | Level 3 | 447.0929, 506.1017 | M(13C)–H[−], M + CH3COO[−] | ||
| C01617 | Taxifolin | ↓ | CP | 1.77 | −2.85 | 0.6 | Level 3 | 287.0548 | M–H2O + H[1+] | ||
| C05631 | Eriodictyol | ↓ | CP | 1.77 | −2.85 | 0.6 | Level 3 | 287.0548 | M[1 + ] | ||
| C05909 | Leucodelphinidin | ↓ | CP | 1.77 | −2.85 | 0.6 | Level 3 | 287.0548 | M–H4O2 + H[1+] | ||
| C00327 | ↓ | HP | 1.66 | −4.25 | 0.7 | Level 2 | 176.1038, 159.0772 | 159.0766 | M–NH3 + H[1+] | ||
| C00065 | ↓ | HP | 1.51 | −4.41 | 0.6 | Level 1 | 106.0506 | ||||
| C01092 | 8-Amino-7-Oxononanoate | ↓ | CN | 1.75 | −4.91 | 0.7 | Level 3 | 223.0608 | M + K-2H[−] | ||
| C02666 | Coniferyl Aldehyde | ↓ | CN | 1.75 | −4.91 | 0.7 | Level 2 | 177.0550, 162.0321 | 193.0501, 223.0608 | M–H + O[−], M + HCOO[−] | |
| C05610 | Sinapoyl Aldehyde | ↓ | CN | 1.75 | −4.91 | 0.7 | Level 3 | 207.0658, 223.0608 | M–H[−], M–H + O[−] | ||
| C03319 | DTDP-Beta- | ↓ | HP | 2.15 | −5.04 | 0.8 | Level 3 | 501.0645 | M–HCOOH + H[1+] | ||
| C11907 | DTDP-4-Dehydro-6-Deoxy-Alpha-D-Glucopyranose | ↓ | HP | 2.15 | −5.04 | 0.8 | Level 3 | 501.0645 | M–CO2 + H[1+] | ||
| C00021 | S-Adenosyl- | ↓ | CN | 1.75 | −5.71 | 0.7 | Level 3 | 385.1138 | M(34S)–H[−] | ||
| C01175 | 1-O-Sinapoyl-Beta- | ↓ | CN | 1.75 | −5.71 | 0.7 | Level 2 | 385.1133, 205.0499, 191.0554 | 385.1138, 367.103 | M–H[−], M–H2O–H[−] | |
| C16827 | 1-O-(4-Coumaroyl)-Beta- | ↓ | CN | 1.75 | −5.71 | 0.7 | Level 3 | 341.0875, 371.098, 385.1138 | M–H + O[−], M + HCOO[−], M + CH3COO[−] | ||
HP, HN, CP and CN denote different analytical streams corresponding to HILIC positive, negative and C18 positive and negative, respectively; a positive t stat value indicates high- > low-sugar group (↑), whereas a negative value indicates high- < low-sugar group (↓); area under the curve (AUC) is a summary statistic for receiver–operator characteristic (ROC) curves, and denotes the trade-off between the specificity and sensitivity of a compound to enable binary classification of the two groups. On a rough scale, AUC values of 0.9–1.0 = excellent, 0.8–0.9 = good, 0.7–0.8 = fair, 0.6–0.7 = poor and 0.5–0.6 = fail, denote respective powers of the compound to direct binary classification[79]; compounds with matches in the library, spectral database or Mummichog were scored with 1, 2 or 3 levels of confidence, respectively[44].
KEGG pathway modules and hierarchical bin structure for MapMan style representation of compounds identified in Table 1, matched with rice reference pathways (osa) using KEGG Mapper
| Bin code | Name | Module | Reaction | Compound | KEGG ID | |
|---|---|---|---|---|---|---|
| 1 | Metabolic pathways | |||||
| 1.1 |
| |||||
| 1.1.1 |
| |||||
| 1.1.1.1 | Methionine degradation | M00035 | S-Adenosyl- | S-Adenosyl- | C00021 | ↓ |
| 1.1.1.2 | Methionine degradation | M00035 | C00065 | ↓ | ||
| 1.1.1.3 | Cysteine biosynthesis | M00609 | Methionine → Cysteine | S-Adenosyl- | C00021 | ↓ |
| 1.1.1.4 | Cysteine biosynthesis | M00021 | Serine → Cysteine | C00065 | ↓ | |
| 1.1.1.5 | Cysteine biosynthesis | M00338 | Homocysteine + Serine → Cysteine | C00065 | ↓ | |
| 1.1.2 |
| |||||
| 1.1.2.1 | Serine biosynthesis | M00020 | Glycerate-3P → Serine | C00065 | ↓ | |
| 1.1.3 |
| |||||
| 1.1.3.1 | Ascorbate degradation | M00550 | Ascorbate → | C00231 | ↑ | |
| 1.1.3.2 | Pantothenate biosynthesis | M00119 | Valine/ | 2-Dehydropantoate | C00966 | ↑ |
| 1.1.3.3 | Biotin biosynthesis | M00123 | Pimeloyl-ACP/CoA → Biotin | 8-Amino-7-Oxononanoate | C01092 | ↓ |
| 1.1.3.4 | Biotin biosynthesis, BioI pathway | M00573 | Long-chain-acyl-ACP → Pimeloyl-ACP → Biotin | 8-Amino-7-Oxononanoate | C01092 | ↓ |
| 1.1.3.5 | Biotin biosynthesis, BioW pathway | M00577 | Pimelate → Pimeloyl-CoA → Biotin | 8-Amino-7-Oxononanoate | C01092 | ↓ |
| 1.1.3.6 | Ascorbate biosynthesis | M00114 | Glucose 6-Phosphate → Ascorbate | C01825 | ↑ | |
| 1.1.3.7 | Riboflavin biosynthesis | M00125 | GTP → Riboflavin/FMN/FAD | 6,7-Dimethyl-8-( | C04332 | ↑ |
| 1.1.4 |
| |||||
| 1.1.4.1 | Urea cycle | M00029 | C00327 | ↓ | ||
| 1.1.5 |
| |||||
| 1.1.5.1 | Valine/Isoleucine biosynthesis | M00019 | Pyruvate → Valine/2-Oxobutanoate → Isoleucine | (S)-2-Aceto-2-Hydroxybutanoate | C06006 | ↑ |
| 1.1.5.2 | Isoleucine biosynthesis | M00570 | Threonine → 2-Oxobutanoate → Isoleucine | (S)-2-Aceto-2-Hydroxybutanoate | C06006 | ↑ |
| 1.2 |
| |||||
| 1.2.1 |
| |||||
| 1.2.1.1 | Ceramide biosynthesis | M00094 | C00065 | ↓ | ||
| 1.2.1.2 | Inositol phosphate metabolism | M00131 | Ins(1,3,4,5)P4 → Ins(1,3,4)P3 → Myo-inositol | Myo-Inositol | C00137 | ↑ |
| 1.2.2 |
| |||||
| 1.2.2.1 | Photorespiration | M00532 | C00065 | ↓ | ||
| 1.2.2.2 | Nucleotide sugar biosynthesis | M00554 | Galactose → UDP-Galactose | C00124 | ↑ | |
| 1.2.2.3 | Galactose degradation, Leloir pathway | M00632 | Galactose → Alpha-D-Glucose 1-Phosphate | C00124 | ↑ | |
| 1.2.2.4 | Glucuronate pathway, Uronate pathway | M00014 | C00231 | ↑ | ||
| 1.2.2.5 | Nucleotide sugar biosynthesis | M00549 | Glucose → UDP-Glucose | Alpha- | C00267 | ↑ |
| 1.2.2.6 | Trehalose biosynthesis | M00565 | D-Glucose 1-Phosphate → Trehalose | alpha,alpha-Trehalose | C01083 | ↑ |
| 1.2.3 |
| |||||
| 1.2.3.1 | Glycolysis (Embden–Meyerhof pathway) | M00001 | Glucose → Pyruvate | Glycerone Phosphate | C00111 | ↑ |
| 1.2.3.2 | Glycolysis, core module involving three-carbon compounds | M00002 | Glycerone Phosphate | C00111 | ↑ | |
| 1.2.3.3 | Gluconeogenesis | M00003 | Oxaloacetate → Fructose 6-Phosphate | Glycerone Phosphate | C00111 | ↑ |
| 1.2.3.4 | Pentose phosphate pathway (pentose phosphate cycle) | M00004 | C00117 | ↑ | ||
| 1.2.3.5 | PRPP biosynthesis | M00005 | Ribose 5-Phosphate → PRPP | C00117 | ↑ | |
| 1.2.3.6 | Pentose phosphate pathway, non-oxidative phase | M00007 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00117 | ↑ | |
| 1.2.3.7 | Pentose phosphate pathway, archaea | M00580 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00117 | ↑ | |
| 1.2.3.8 | Pentose phosphate pathway (pentose phosphate cycle) | M00004 | C00231 | ↑ | ||
| 1.2.3.9 | Pentose phosphate pathway, non-oxidative phase | M00007 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00231 | ↑ | |
| 1.2.3.10 | Glycolysis (Embden–Meyerhof pathway) | M00001 | Glucose → Pyruvate | Alpha- | C00267 | ↑ |
| 1.2.4 |
| |||||
| 1.2.4.1 | CMP-KDO biosynthesis | M00063 | C01112 | ↑ | ||
| 1.3 |
| |||||
| 1.3.1 |
| |||||
| 1.3.1.1 | Reductive pentose phosphate cycle (Calvin cycle) | M00165 | C00117 | ↑ | ||
| 1.3.1.2 | Reductive pentose phosphate cycle | M00167 | Glyceraldehyde 3-Phosphate → Ribulose 5-Phosphate | C00117 | ↑ | |
| 1.4 |
| |||||
| 1.4.1 |
| |||||
| 1.4.1.1 | Monolignol biosynthesis | M00039 | Phenylalanine/Tyrosine → Monolignol | Coniferyl Aldehyde | C02666 | ↓ |
| 1.4.1.2 | Monolignol biosynthesis | M00039 | Phenylalanine/Tyrosine → Monolignol | Sinapoyl Aldehyde | C05610 | ↓ |
| 1.5 |
| |||||
| 1.5.1 | Amino acid | C00152 | ↓ | |||
| 1.5.2 | Oligosaccharides | Maltose | C00208 | ↑ | ||
| 1.5.3 | Glycolysis/Gluconeogenesis | Beta- | C00221 | ↑ | ||
| 1.5.4 | Arginine and proline metabolism | 4-Aminobutyraldehyde | C00555 | ↑ | ||
| 1.5.5 | Cysteine and methionine metabolism | O-Acetyl- | C01077 | ↑ | ||
| 1.5.6 | Lipopolysaccharide biosynthesis | C01112 | ↑ | |||
| 1.5.7 | Biosynthesis of secondary metabolites | 1-Aminocyclopropane-1-Carboxylate | C01234 | ↑ | ||
| 1.5.8 | Biosynthesis of phenylpropanoids | Taxifolin | C01617 | ↓ | ||
| 1.5.9 | Ascorbate and aldarate metabolism | C01825 | ↑ | |||
| 1.5.10 | Amino sugar and nucleotide sugar metabolism | Beta- | C03906 | ↑ | ||
| 1.5.11 | Biosynthesis of secondary metabolites | (2S)-2-Isopropyl-3-Oxosuccinate | C04236 | ↑ | ||
| 1.5.12 | Biosynthesis of secondary metabolites | Pelargonidin 3-O-Glucoside | C12137 | ↓ | ||
| 2 | Biosynthesis of secondary metabolites | |||||
| 2.1 |
| |||||
| 2.1.1 |
| |||||
| 2.1.1.1 | Cysteine biosynthesis | M00021 | Serine → Cysteine | C00065 | ↓ | |
| 2.1.1.2 | Ethylene biosynthesis | M00368 | Methionine → Ethylene | 1-Aminocyclopropane-1-Carboxylate | C01234 | ↑ |
| 2.1.2 |
| |||||
| 2.1.2.1 | Pantothenate biosynthesis | M00119 | Valine/ | 2-Dehydropantoate | C00966 | ↑ |
| 2.1.2.2 | Ascorbate biosynthesis | M00114 | Glucose 6-Phosphate → Ascorbate | C01825 | ↑ | |
| 2.1.2.3 | Riboflavin biosynthesis | M00125 | GTP → Riboflavin/FMN/FAD | 6,7-Dimethyl-8-( | C04332 | ↑ |
| 2.1.3 |
| |||||
| 2.1.3.1 | Valine/Isoleucine biosynthesis | M00019 | Pyruvate → Valine/2-Oxobutanoate → Isoleucine | (S)−2-Aceto-2-Hydroxybutanoate | C06006 | ↑ |
| 2.2 |
| |||||
| 2.2.1 |
| |||||
| 2.2.1.1 | Photorespiration | M00532 | C00065 | ↓ | ||
| 2.2.1.2 | Trehalose biosynthesis | M00565 | D-Glucose 1-Phosphate → Trehalose | alpha,alpha-Trehalose | C01083 | ↑ |
| 2.3 |
| |||||
| 2.3.1 |
| |||||
| 2.3.1.1 | Monolignol biosynthesis | M00039 | Phenylalanine/Tyrosine → Monolignol | Coniferyl Aldehyde | C02666 | ↓ |
| 2.3.1.2 | Monolignol biosynthesis | M00039 | Phenylalanine/Tyrosine → Monolignol | Sinapoyl Aldehyde | C05610 | ↓ |
| 2.4 |
| |||||
| 2.4.1 | Flavonoid biosynthesis | Eriodictyol | C05631 | ↓ | ||
| 2.4.2 | Flavonoid biosynthesis | Leucodelphinidin | C05909 | ↓ | ||
| 2.4.3 | Biosynthesis of phenylpropanoids | Umbelliferone | C09315 | ↓ | ||
| 2.4.4 | Biosynthesis of secondary metabolites | Pelargonidin 3-O-Glucoside | C12137 | ↓ | ||
| 2.4.5 | Biosynthesis of phenylpropanoids | Taxifolin | C01617 | ↓ | ||
| 2.4.6 | Biosynthesis of secondary metabolites | 2-Isopropylmaleate | C02631 | ↑ | ||
| 2.4.7 | Biosynthesis of secondary metabolites | (2S)-2-Isopropyl-3-Oxosuccinate | C04236 | ↑ | ||
| 3 | Biosynthesis of amino acids | |||||
| 3.1 |
| |||||
| 3.1.1 |
| |||||
| 3.1.1.1 | Cysteine biosynthesis | M00609 | Methionine → Cysteine | S-Adenosyl- | C00021 | ↓ |
| 3.1.1.2 | Cysteine biosynthesis | M00021 | Serine → Cysteine | C00065 | ↓ | |
| 3.1.1.3 | Cysteine biosynthesis | M00338 | Homocysteine + Serine → Cysteine | C00065 | ↓ | |
| 3.1.2 |
| |||||
| 3.1.2.1 | Serine biosynthesis | M00020 | Glycerate 3-Phosphate → Serine | C00065 | ↓ | |
| 3.1.3 |
| |||||
| 3.1.3.1 | Urea cycle | M00029 | C00327 | ↓ | ||
| 3.1.3.2 | Arginine biosynthesis | M00844 | Ornithine → Arginine | C00327 | ↓ | |
| 3.1.3.3 | Arginine biosynthesis | M00845 | Glutamate → Acetylcitrulline → Arginine | C00327 | ↓ | |
| 3.1.4 |
| |||||
| 3.1.4.1 | Valine/Isoleucine biosynthesis | M00019 | Pyruvate → Valine/2-Oxobutanoate → Isoleucine | (S)-2-Aceto-2-Hydroxybutanoate | C06006 | ↑ |
| 3.1.4.2 | Isoleucine biosynthesis | M00570 | Threonine → 2-Oxobutanoate → Isoleucine | (S)-2-Aceto-2-Hydroxybutanoate | C06006 | ↑ |
| 3.2 |
| |||||
| 3.2.1 |
| |||||
| 3.2.1.1 | Glycolysis, core module involving three-carbon compounds | M00002 | Glycerone Phosphate | C00111 | ↑ | |
| 3.2.1.2 | PRPP biosynthesis | M00005 | Ribose 5-Phosphate → PRPP | C00117 | ↑ | |
| 3.2.1.3 | Pentose phosphate pathway, non-oxidative phase | M00007 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00117 | ↑ | |
| 3.2.1.4 | Pentose phosphate pathway, archaea | M00580 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00117 | ↑ | |
| 3.2.1.5 | Pentose phosphate pathway, non-oxidative phase | M00007 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00231 | ↑ | |
| 3.3 |
| |||||
| 3.3.1 | Amino acid | C00152 | ↓ | |||
| 4 | Carbon metabolism | |||||
| 4.1 |
| |||||
| 4.1.1 |
| |||||
| 4.1.1.1 | Serine biosynthesis | M00020 | Glycerate 3-Phosphate → Serine | C00065 | ↓ | |
| 4.1.2 | Cysteine and methionine metabolism | |||||
| 4.1.2.1 | Cysteine biosynthesis | M00021 | Serine → Cysteine | C00065 | ↓ | |
| 4.2 |
| |||||
| 4.2.1 |
| |||||
| 4.2.1.1 | Formaldehyde assimilation, serine pathway | M00346 | C00065 | ↓ | ||
| 4.2.1.2 | Formaldehyde assimilation, xylulose monophosphate pathway | M00344 | Glycerone Phosphate | C00111 | ↑ | |
| 4.2.1.3 | Formaldehyde assimilation, ribulose monophosphate pathway | M00345 | Glycerone Phosphate | C00111 | ↑ | |
| 4.2.2 |
| |||||
| 4.2.2.1 | Reductive pentose phosphate cycle (Calvin cycle) | M00165 | C00117 | ↑ | ||
| 4.2.2.2 | Reductive pentose phosphate cycle | M00167 | Glyceraldehyde 3-Phosphate → Ribulose 5-Phosphate | C00117 | ↑ | |
| 4.3 |
| |||||
| 4.3.1 |
| |||||
| 4.3.1.1 | Glycolysis (Embden-Meyerhof pathway) | M00001 | Glucose → Pyruvate | Glycerone Phosphate | C00111 | ↑ |
| 4.3.1.2 | Glycolysis, core module involving three-carbon compounds | M00002 | Glycerone Phosphate | C00111 | ↑ | |
| 4.3.1.3 | Pentose phosphate pathway (Pentose phosphate cycle) | M00004 | C00117 | ↑ | ||
| 4.3.1.4 | PRPP biosynthesis | M00005 | Ribose 5-Phosphate → PRPP | C00117 | ↑ | |
| 4.3.1.5 | Pentose phosphate pathway, non-oxidative phase | M00007 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00117 | ↑ | |
| 4.3.1.6 | Pentose phosphate pathway, archaea | M00580 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00117 | ↑ | |
| 4.3.1.7 | Pentose phosphate pathway (Pentose phosphate cycle) | M00004 | C00231 | ↑ | ||
| 4.3.1.8 | Pentose phosphate pathway, non-oxidative phase | M00007 | Fructose 6-Phosphate → Ribose 5-Phosphate | C00231 | ↑ | |
| 4.3.1.9 | Glycolysis (Embden-Meyerhof pathway) | M00001 | Glucose → Pyruvate | Alpha- | C00267 | ↑ |
| 4.3.2 |
| |||||
| 4.3.2.1 | Photorespiration | M00532 | C00065 | ↓ | ||
| 4.4 |
| |||||
| 4.4.1 | Glycolysis/Gluconeogenesis | Beta- | C00221 | ↑ | ||
| 5 | Galactose metabolism | |||||
| 5.1 | Glycolysis, core module involving three-carbon compounds | Glycerone Phosphate | C00111 | ↑ | ||
| 5.2 | Galactose degradation | C00124 | ↑ | |||
| 5.3 | Inositol phosphate metabolism | Myo-Inositol | C00137 | ↑ | ||
| 5.4 | Glycolysis (Embden–Meyerhof pathway) | Alpha- | C00267 | ↑ | ||
| 5.5 | Galactose metabolism | Galactinol | C01235 | ↑ | ||
| 6 | ABC transporters | |||||
| 6.1 | Phosphate and amino acid transporters | C00065 | ↓ | |||
| 6.2 | Monosaccharide transporters | Myo-Inositol | C00137 | ↑ | ||
| 6.3 | Oligosaccharide, polyol, and lipid transporters | Maltose | C00208 | ↑ | ||
| 6.4 | Oligosaccharide, polyol, and lipid transporters | alpha,alpha-trehalose | C01083 | ↑ | ||
| 7 | Cysteine and methionine metabolism | |||||
| 7.1 | Methionine degradation | M00035 | S-Adenosyl- | C00021 | ↓ | |
| 7.2 | Glycine, serine and threonine metabolism | C00065 | ↓ | |||
| 7.3 | Aspartate metabolism | O-Acetyl- | C01077 | ↑ | ||
| 7.4 | Propanoate metabolism | 1-Aminocyclopropane-1-Carboxylate | C01234 | ↑ | ||
| 8 | Flavonoid biosynthesis | |||||
| 8.1 | Flavone and flavonol biosynthesis | Vitexin | C01460 | ↓ | ||
| 8.2 | Flavone and flavonol biosynthesis | Taxifolin | C01617 | ↓ | ||
| 8.3 | Flavanone biosynthesis | Eriodictyol | C05631 | ↓ | ||
| 8.4 | Flavan 3,4-diols biosynthesis | Leucodelphinidin | C05909 | ↓ | ||
| 9 | Glycerophospholipid metabolism | |||||
| 9.1 | Ether lipid metabolism | Glycerone Phosphate | C00111 | ↑ | ||
| 9.2 | Phosphocholine biosynthesis | N-Methylethanolamine Phosphate | C01210 | ↑ | ||
| 9.3 | Phosphocholine biosynthesis | Phosphodimethylethanolamine | C13482 | ↑ | ||
| 10 | Glycolysis/gluconeogenesis | |||||
| 10.1 | Core module involving three-carbon compounds | Glycerone Phosphate | C00111 | ↑ | ||
| 10.2 | Starch and sucrose metabolism | Beta- | C00221 | ↑ | ||
| 10.3 | Starch and sucrose metabolism | Alpha- | C00267 | ↑ | ||
| 11 | Amino sugar and nucleotide sugar metabolism | |||||
| 11.1 | Uridine diphosphate sugar metabolism | Alpha- | C00267 | ↑ | ||
| 11.2 | Uridine diphosphate sugar metabolism | Beta- | C02336 | ↑ | ||
| 11.3 | Uridine diphosphate sugar metabolism | Beta- | C03906 | ↑ | ||
| 12 | Carbon fixation in photosynthetic organisms | |||||
| 12.1 | Glycolysis | Glycerone Phosphate | C00111 | ↑ | ||
| 12.2 | Reductive pentose phosphate cycle | C00117 | ↑ | |||
| 12.3 | Reductive pentose phosphate cycle | C00231 | ↑ | |||
| 13 | 2-Oxocarboxylic acid metabolism | |||||
| 13.1 | Pyruvate reductive amination | 2-Isopropylmaleate | C02631 | ↑ | ||
| 13.2 | Pyruvate reductive amination | (2S)−2-Isopropyl-3-Oxosuccinate | C04236 | ↑ | ||
| 13.3 | Pyruvate reductive amination | (S)−2-Aceto-2-Hydroxybutanoate | C06006 | ↑ | ||
| 14 | Phenylpropanoid biosynthesis | |||||
| 14.1 | Sinapate derivatives | 1-O-Sinapoyl-Beta- | C01175 | ↓ | ||
| 14.2 | Coniferyl alcohol derivatives | Coniferyl Aldehyde | C02666 | ↓ | ||
| 14.3 | Sinapate derivatives | Sinapoyl Aldehyde | C05610 | ↓ | ||
| 15 | Pentose phosphate pathway | |||||
| 15.1 | PRPP biosynthesis | Ribose 5-Phosphate → PRPP | C00117 | ↑ | ||
| 15.2 | PRPP biosynthesis | Beta- | C00221 | ↑ | ||
| 15.3 | PRPP biosynthesis | C00231 | ↑ | |||
| 16 | Anthocyanin biosynthesis | |||||
| 16.1 | Flavonoids | Chrysanthemin | C08604 | ↓ | ||
| 16.2 | Flavonoids | Pelargonidin 3-O-Glucoside | C12137 | ↓ | ||
| 16.3 | Flavonoids | Cyanidin 5-O-Glucoside | C16298 | ↓ | ||
| 17 | Ascorbate and aldarate metabolism | |||||
| 17.1 | Sugar alcohols | Myo-Inositol | C00137 | ↑ | ||
| 17.2 | Ascorbate degradation | Ascorbate → | C00231 | ↑ | ||
| 17.3 | Aldoses | C01825 | ↑ | |||
| 18 | Valine, leucine and isoleucine biosynthesis | |||||
| 18.1 | Pyruvate metabolism | 2-Isopropylmaleate | C02631 | ↑ | ||
| 18.2 | Leucine biosynthesis | (2S)-2-Isopropyl-3-Oxosuccinate | C04236 | ↑ | ||
| 18.3 | Isoleucine biosynthesis | (S)-2-Aceto-2-Hydroxybutanoate | C06006 | ↑ | ||
| 19 | Glycine, serine and threonine metabolism | |||||
| 19.1 | Pyruvate, cysteine and tryptophan metabolism | C00065 | ↓ | |||
| 20 | Pentose and glucuronate interconversions | |||||
| 20.1 | Glucuronate interconversion | Glycerone Phosphate | C00111 | ↑ | ||
| 20.2 | Pentose interconversion | C00231 | ↑ | |||
| 21 | Fructose and mannose metabolism | |||||
| 21.1 | Core module involving three-carbon compounds | Glycerone Phosphate | C00111 | ↑ | ||
| 21.2 | Fructose biosynthesis | Alpha- | C00267 | ↑ | ||
| 22 | Starch and sucrose metabolism | |||||
| 22.1 | Oligosaccharides | Maltose | C00208 | ↑ | ||
| 22.2 | Oligosaccharides | alpha,alpha-Trehalose | C01083 | ↑ | ||
| 23 | Inositol phosphate metabolism | |||||
| 23.1 | Core module involving three-carbon compounds | Glycerone Phosphate | C00111 | ↑ | ||
| 23.2 | Inositol phosphate metabolism | Ins(1,3,4,5)P4 → Ins(1,3,4)P3 → Myo-Inositol | Myo-Inositol | C00137 | ↑ | |
| 24 | Flavone and flavonol biosynthesis | |||||
| 24.1 | Flavones | Vitexin | C01460 | ↓ | ||
| 24.2 | Flavones | Isovitexin | C01714 | ↓ | ||
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis | |||||
| 25.1 | Shikimate pathway | Quinate | C00296 | ↑ | ||
KEGG pathways and modules that involve compounds identified in Table 1 were generated by KEGG Mapper[75]; Bin codes denote the hierarchical structure of KEGG pathways and modules used to generate MapMan[77] style representation of the identified compounds (Fig. 4); ↑ refers to a compound with positive t stat value (high- > low-sugar group), whereas ↓ refers to a compound with a negative t stat value (high- < low-sugar group).
Fig. 5Pictorial representation of biochemical activity of high-sugar grasses in MapMan[77] (Ver 3.6.0RC1; copyright of the Max–Planck-Institute for Molecular Plant Physiology, Golm, Germany), depicting KEGG pathways and modules involving the compounds identified in Table 1, with rice pathways (osa) as a reference (Table 2). Dots represent compounds identified in respective modules, where red dots denote compounds with positive t stat value (high- > low-sugar group), and blue dots denote compounds with negative t stat value (high- < low-sugar group). CHO: carbohydrates, Bra-AA: branched chain amino acids, CoF and Vit: cofactor and vitamins, ABC: ATP-binding cassette
Fig. 6Summarised overview of data analysis from raw files of fructan data through to total sugar content, classification of high- and low-sugar groups, and subsequent analysis of fatty acid methyl esters (FAMEs), lipids, polar and semi-polar compounds